INVIVO THERAPEUTICS HOLDINGS CORP. Quarterly Return On Assets in % from Q1 2012 to Q3 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Invivo Therapeutics Holdings Corp. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q3 2023.
  • Invivo Therapeutics Holdings Corp. Return On Assets for the quarter ending September 30, 2023 was -65 %, a 2.65% decline year-over-year.
  • Invivo Therapeutics Holdings Corp. annual Return On Assets for 2022 was -62.8 %, a 56.9% decline from 2021.
  • Invivo Therapeutics Holdings Corp. annual Return On Assets for 2021 was -40 %, a 36.5% increase from 2020.
  • Invivo Therapeutics Holdings Corp. annual Return On Assets for 2020 was -63 %, a 32% increase from 2019.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2023 -65 -1.68 -2.65% Jul 1, 2023 Sep 30, 2023
Q2 2023 -61.4 -7.66 -14.3% Apr 1, 2023 Jun 30, 2023
Q1 2023 -63.6 -17.6 -38.2% Jan 1, 2023 Mar 31, 2023
Q4 2022 -62.8 -22.8 -56.9% Oct 1, 2022 Dec 31, 2022
Q3 2022 -63.3 -26.3 -70.8% Jul 1, 2022 Sep 30, 2022
Q2 2022 -53.7 -11.8 -28.2% Apr 1, 2022 Jun 30, 2022
Q1 2022 -46.1 +2.72 +5.58% Jan 1, 2022 Mar 31, 2022
Q4 2021 -40 +23 +36.5% Oct 1, 2021 Dec 31, 2021
Q3 2021 -37.1 +54 +59.3% Jul 1, 2021 Sep 30, 2021
Q2 2021 -41.9 +51.5 +55.1% Apr 1, 2021 Jun 30, 2021
Q1 2021 -48.8 +51.1 +51.1% Jan 1, 2021 Mar 31, 2021
Q4 2020 -63 +29.7 +32% Oct 1, 2020 Dec 31, 2020
Q3 2020 -91.1 -18 -24.7% Jul 1, 2020 Sep 30, 2020
Q2 2020 -93.4 -28.2 -43.2% Apr 1, 2020 Jun 30, 2020
Q1 2020 -99.8 +5.63 +5.34% Jan 1, 2020 Mar 31, 2020
Q4 2019 -92.7 +29 +23.8% Oct 1, 2019 Dec 31, 2019
Q3 2019 -73.1 +67.6 +48% Jul 1, 2019 Sep 30, 2019
Q2 2019 -65.2 +117 +64.2% Apr 1, 2019 Jun 30, 2019
Q1 2019 -105 +39.2 +27.1% Jan 1, 2019 Mar 31, 2019
Q4 2018 -122 +3.93 +3.13% Oct 1, 2018 Dec 31, 2018
Q3 2018 -141 -36.8 -35.4% Jul 1, 2018 Sep 30, 2018
Q2 2018 -182 -105 -137% Apr 1, 2018 Jun 30, 2018
Q1 2018 -145 -81.4 -129% Jan 1, 2018 Mar 31, 2018
Q4 2017 -126 -69 -122% Oct 1, 2017 Dec 31, 2017
Q3 2017 -104 -44.3 -74.2% Jul 1, 2017 Sep 30, 2017
Q2 2017 -76.9 -21.8 -39.6% Apr 1, 2017 Jun 30, 2017
Q1 2017 -63.3 +16.6 +20.8% Jan 1, 2017 Mar 31, 2017
Q4 2016 -56.7 +76.6 +57.5% Oct 1, 2016 Dec 31, 2016
Q3 2016 -59.6 +96.1 +61.7% Jul 1, 2016 Sep 30, 2016
Q2 2016 -55 +102 +65% Apr 1, 2016 Jun 30, 2016
Q1 2016 -79.9 +52.8 +39.8% Jan 1, 2016 Mar 31, 2016
Q4 2015 -133 -33.7 -33.8% Oct 1, 2015 Dec 31, 2015
Q3 2015 -156 -71.2 -84.2% Jul 1, 2015 Sep 30, 2015
Q2 2015 -157 -51.8 -49.2% Apr 1, 2015 Jun 30, 2015
Q1 2015 -133 +24.8 +15.8% Jan 1, 2015 Mar 31, 2015
Q4 2014 -99.6 +98.2 +49.6% Oct 1, 2014 Dec 31, 2014
Q3 2014 -84.6 +131 +60.8% Jul 1, 2014 Sep 30, 2014
Q2 2014 -105 +47.1 +30.9% Apr 1, 2014 Jun 30, 2014
Q1 2014 -157 -88.4 -128% Jan 1, 2014 Mar 31, 2014
Q4 2013 -198 -222 -905% Oct 1, 2013 Dec 31, 2013
Q3 2013 -216 -83.2 -62.7% Jul 1, 2013 Sep 30, 2013
Q2 2013 -153 +54.1 +26.2% Apr 1, 2013 Jun 30, 2013
Q1 2013 -69.1 +252 +78.5% Jan 1, 2013 Mar 31, 2013
Q4 2012 24.6 Oct 1, 2012 Dec 31, 2012
Q3 2012 -133 Jul 1, 2012 Sep 30, 2012
Q2 2012 -207 Apr 1, 2012 Jun 30, 2012
Q1 2012 -321 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.